-
Identification of a Stable Gene Signature of Transplant Tolerance to Liver Allograft by Meta-Analysis.
-
Identification of Antibody-Mediated Rejection After Kidney Transplantation by Specific MicroRNAs.
-
Identification of Kidney Transplant Patients at Risk for Skin Cancer by Differentially Methylated Regions in T Cells.
-
Identification of NKG2D as Senescence Marker in Zero-Hour Kidney Biopsies Is Indicative for Clinical Outcome.
-
Identification of Novel Diagnostic Biomarkers in Liver Transplantation Tolerance.
-
Identification of Plasma Protein Biomarkers of Acute Renal Allograft Rejection.
-
Identification of Promising Targets for Tolerance Induction Following Heart Transplantation.
-
Identify Clinical and Masked Hypertension and Management Strategies in Pediatric Liver Transplant Patients.
-
Identifying Independent Risk Factors for Graft Loss After Primary Liver Transplantation: A Propensity Score Matched Analysis.
-
Identifying Risk of Sepsis Early: A Way to Improve Outcomes for Patients with Early Allograft Dysfunction After Liver Transplantation?
-
Identifying Risks and Screening Deceased Organ Donors in the UK for Trypanosoma cruzi .
-
Identifying the Specific Causes and the Determinants of Outcome in Kidney Recipients with Transplant Glomerulopathy: A Multicenter Study.
-
IdeS, an IgG Endopeptidase, Effectively Cleaves Anti-CMV IgG, Resulting in Inhibition of Antibody (Ab)-Mediated NK Cell Activation in Kidney Transplant Patients (KTX Pts).
-
IdeS, an IgG Endopeptidase, Effectively Cleaves Anti-HLA Antibody (Ab), Resulting in Inhibition of Anti-HLA Ab-Mediated NK Cell Activation and Ab-Dependent Cell-Mediated Cytotoxicity (ADCC) in HLA-Sensitized Kidney Transplant Patients (HS KTx Pts).
-
IgG Antibody Subclasses in Potential Renal Transplant Recipients with DSA, AHG-CDC CxM Negative and FxM Positive or Negative with Their Potential Donors.
-
IgM Immunotherapy Restores Immune Homeostasis in Type 1 Diabetes.
-
IL-21R Antagonist Inhibits Differentiation of B Cells Towards Plasmablasts upon Alloantigen Stimulation.
-
IL-3 Contributes to Development of Basophil-Triggered Cardiac Allograft Fibrosis Development.
-
IL-33 Enhances the Ability of Dendritic Cells to Expand Human Regulatory T Cells.
-
IL-7 Receptor Heterogeneity as a Mechanism for Repertoire Change During Post-Depletional Homeostatic Proliferation and Its Relation to Costimulation Blockade Resistant Rejection.
-
Imaging Cell Biology in Transplantation.
-
Immediate vs Delayed Initiation of CMV Prophylaxis…Safe and Cost Beneficial?
-
Immediate vs. Delayed Kidney Implantation Is Associated with Improved Kidney Graft Survival in Combined Liver-Kidney Transplantation.
-
Immune Activation and Rejection Risk in HIV-Positive Kidney Transplantation.
-
Immune Monitoring-Guided Treatment of a Pediatric Patient with Sequential GvHD, Acute Rejection and CMV Infection Following Lung Transplantation.
-
Immune Sensitization During Pregnancy Reduces Long-Term Benefit for Kidney Recipients of Offspring Living Donors.
-
Immune Tolerance Monitoring in Renal Allograft Tolerance Induced by Transient Mixed Chimerism in Nonhuman Primates.
-
Immunodominant Donor Specific Antibody Reduction with Proteasome Inhibitor Based Treatment: Clinical Variability and Implications for Long Term Graft Survival.
-
Immunoregulatory Roles of CD137 Signaling in Graft-versus-Host Disease.
-
Immunosuppressant Costs for Medicare Part D and Kidney Transplant Recipients Since the Introduction of Generic Formulations in an Incident Kidney Transplant Population.
-
Immunosuppression (IS) Withdrawal (ISW) After ATG and Rituximab in Kidney Transplant Recipients (KTR): RESTARRT Early Results (NCT01318915).
-
Immunosuppression and Graft Rejection in Living-Related HLA-Identical Renal Transplantation.
-
Immunosuppressive Ability of NFkB Inhibitor: Withaferin A.
-
Immunosuppressive Regimen Modification Approaches in BK Nephropathy – A Comparative Study.
-
Immunosuppressive Role of Pancreas Derived Mesenchymal Stem Cells.
-
Immunosuppressive Therapy and Acute Rejection in Combined Heart and Kidney Transplantation.
-
Immunosuppressive Treatment Alters Gut Microbiota and Modified Gut Microbiota Affects Immune Status.
-
Impact of a B-Cell Targeting Agent on Antibody Mediated Rejection and Graft' Survival in Liver Transplantation with Preformed DSAs.
-
Impact of a Novel Prehabilitation Program in Kidney Transplant Candidates.
-
Impact of a Pharmacist-Led Vaccine Recommendation Program for Pediatric Kidney Transplant Candidates.
-
Impact of Alemtuzumab Induction on Hepatitis C Treatment Outcomes Post-Renal Transplantation.
-
Impact of Antibiotic Treatment Duration for Symptomatic Lower Urinary Tract Infections in Kidney Transplant Recipients.
-
Impact of Antihypertensive (AHT) Choice and Advagraf® Dose on Immunologic Events in Renal Allografts 24 Months Post-Transplantation (Tx).
-
Impact of Antihypertensive (AHT) Choice and Advagraf® Dose on Interstitial Fibrosis/Tubular Atrophy (IF/TA) and IF/TA Progression in Renal Allografts 24 Months Post-Transplantation (Tx).
-
Impact of Bariatric Surgery on Risk of Organ Rejection Among Solid Organ Transplant Recipients.
-
Impact of Belatacept Conversion on Kidney Transplant Function, Histology and Gene Expression.
-
Impact of Body Mass Index and Waist Circumference in Kidney Transplant Recipients.
-
Impact of Caregiver on 30 Day Readmission After Lung Transplant.
-
Impact of Cognitive Impairment on Kidney Transplantation Listing Between Sexes.
-
Impact of Cold Ischemia Time on Outcomes in Kidney Paired Donation (KPD).
-
Impact of Complement Component 3 Single Nuclear Polymorphisms on Renal Transplant Recipients with Antibody-Mediated Rejection.
-
Impact of Culture Expansion and Inflammatory Cytokine Challenge on DNA Methylation Profiles in MSC.
-
Impact of Cytokine Gene Polymorphism on Clinical Outcome of Renal Transplantation.
-
Impact of Dialysis During the Transplant Admission on Transplant and Post-Transplant Cost of Care.
-
Impact of Donor Asystole in Intestine Transplant.
-
Impact of Donor BK-Virus Replication on Posttransplant BKV Replication After Living-Donor Transplantation.
-
Impact of Donor Genotype on Recipient Tacrolimus Pharmacokinetics: The Liver Matters.
-
Impact of Early Allograft Dysfunction on Graft and Patient Outcomes After Liver Transplantation.
-
Impact of Early Pancreas Graft Failure on Patient and Kidney Graft Survival After Simultaneous Pancreas and Kidney Transplantation (SPK).
-
Impact of Everolimus Added to a De Novo Belatacept Regimen on the Risk of BK Viremia After Kidney Transplant.
-
Impact of Filgrastim Use on Maintenance Doses of Immunosuppressants and Clinical Outcomes in Renal Transplant Patients.
-
Impact of Immunosuppression Adherence on De Novo Donor-Specific Antibody Formation in Renal Transplant Recipients in Canada: A Modeling Analysis.
-
Impact of Induction Immunosuppression on the Recurrence of Primary IgA Nephropathy.
-
Impact of Inflammatory Bowel Disease on Survival and Risk of Retransplantation of Primary Sclerosing Cholangitis Patients Following Liver Transplantation: UNOS Data Analysis.
-
Impact of Intensive Dosing of Mycophenolate on Pancreas Allograft Survival.
-
Impact of mTOR-Inhibition on Tolerance-Induction Following Heart Transplantation.
-
Impact of NODAT on Post-Transplant Survival – An Analysis of UNOS Data.
-
Impact of Non-Adherence in a Cohort of Kidney Transplant Recipients.
-
Impact of Pancreas Transplant Failure in Quality of Life in Simultaneous Kidney Pancreas Transplantation.
-
Impact of Pancreatic Texture Assessment on Islet Isolation and Metabolic Outcome After TPIAT.
-
Impact of Pediatric Lung Transplant on Quality of Life Outcomes.
-
Impact of Peri-Transplant Viral Upper Respiratory Infection on Pediatric Liver Transplant Outcomes.
-
Impact of Polymorphisms of UGT 1 A9 on the Prognosis of Renal Transplant Patients. Association with Digestive Tumors.
-
Impact of Post Kidney Donation Gout on eGFR and Kidney Stones.
-
Impact of Pre-Donation eGFR on Long-Term Post-Donation eGFR in Younger Living Kidney Donors.
-
Impact of Pretransplant Panel-Reactive Antibody Level on Ocular Surface Stem Cell Survival and Visual Outcome.
-
Impact of Race on Selection of the Living Donor Candidate.
-
Impact of Ritonavir on Graft Function in Human Immunodeficiency Virus Infected Kidney Transplant Recipients.
-
Impact of Serum EDTA Treatment on Identification of Unacceptable Antigens for Kidney Transplant Candidates.
-
Impact of Six-Month Surveillance Biopsies and Monitoring in Pediatric Renal Transplant Recipients.
-
Impact of STEEN vs Gelofusine as Perfusate During Normothermic Ex Vivo liver Perfusion on Outcome of Pig Liver Transplantation.
-
Impact of T-Cell Depletion on CMV-Specific Memory T and B Cell Homeostatic Proliferation After Kidney Transplantation.
-
Impact of Timeliness of Assessment of Positive Cytomegalovirus Polymerase Chain Reaction Results in Abdominal Organ Transplant Recipients.
-
Impact of Type 2 Surgical Injuries in Postmortem Donor Kidneys on the Post-Transplant Outcomes When Compared to Mate Non-Injured Kidney from the Same Donor.
-
Impact of Type of Kidney (Living vs. Deceased) on Urinary Podocyte Excretion Rate in Renal Allografts.
-
Impact of Type of Recipient Diabetes on 1 and 3-Year Kidney Allograft and Patient Outcomes.
-
Impact of Visceral and Subcutaneous Adipose Tissue on Post Donation Renal Function in Living Kidney Donors.
-
Impairment of Glucose Tolerance After Pediatric Kidney Transplant Is Associated with Worse Systemic Insulin Sensitivity Rather Than Fall in Insulin Secretion.
-
Implementing a New Specialist Requester Role to the United Kingdom to Address Consent Rates.
-
Implementing a Successful DCD Heart Programme to the United Kingdom.
-
Importance of Acquisition of Carbapenemase (KPC)-Producing Enterobacteriaceae in Solid Organ Transplant Recipients: A Single-Center Experience.
-
Importance of B Cell Antigen Specificity in Breg Dependent Tolerance.
-
Importance of HLA-DR Expression in Pediatric Renal Transplant Biopsies.
-
Improved Creatinine Immediately Post-LVAD Predicts Lower AKI Risk After Heart Transplant.
-
Improved Method to Obtain High Islet Mass from Severely Fibrotic Pancreatitis Pancreases Intended for Clinical Islet Auto-Transplantation.
-
Improved Mouse Renal Transplantation Model Simulating Clinical Antibody Mediated Rejection.
-
Improved Outcome of Kidney Transplants by Donor Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes.
-
Improved Outcomes After Liver Transplantation from Controlled DCD Donors with Normothermic Regional Perfusion.
-
Improved Preservation During Normothermic Ex-Vivo Liver Perfusion with Delta Opioid Agonist (D-Ala2, D-Leu5) Enkephalin (DADLE).
-
Improvement in Inflammatory Response Follows Clearance of BKVN.
-
Improvement of Cyclosporine A Dosing Strategy to Enhance Medication Adherence.
-
Improving Clinical Decisions for Kidney Transplant Recipients Through Online Medical Simulation.
-
Improving Communication of SRTR Transplant Program Outcomes Evaluations Using a 5-Tier System.
-
Improving Donor Screening for Cytomegalovirus (CMV): Is CMV IgG Avidity Better Than CMV IgM?
-
Improving Liver Allocation Using Optimized Neighborhoods.
-
Improving Vaccination Rates for Lung Transplant Candidates.
-
Improving Value by Standardizing the Use of IVIG Amongst Pediatric Solid Organ Transplant (SOT) Patients.
-
In Clinic Systems to Address Adherence Barriers Decrease Late Allograft Rejection for Kidney Transplant Patients.
-
In Depth Characterization of Ex Vivo Expanded Polyclonal Regulatory T Cells Used in a Phase I Clinical Trial Following Kidney Transplantation.
-
In Depth Characterization of the Innate Immune Response in Transplant Recipients with EBV Viremia.
-
In Mid Wait Regions Shorter Height and Female Sex Confer Lower Probability of Liver Transplant (LT) Among Patients with Hepatocellular Carcinoma (HCC).
-
In the Modern Era, Cytomegalovirus Does Not Appear to Increase Intimal Thickening After Heart Transplantation.
-
In Vivo Administration of Plerixafor in Humans Mobilizes Bone Marrow Resident Plasma Cells That Demonstrate Apoptosis in Both Bone Marrow and Peripheral Blood.
-
Incidence and Clinical Outcomes of Mycobacterium tuberculosis Infections Following Renal Transplantation in Endemic Country.
-
Incidence and Clinical Outcomes of Active Tuberculosis in Transplant Recipients from a Low Prevalence Region.
-
Incidence and Outcomes of Immediate Post-Operative Dialysis in Liver Transplantation.
-
Incidence and Outcomes of Re-Explorations in Living Donor Liver Transplantation.
-
Incidence and Risk Factors for Cervical Dysplasia Associated to Human Papillomavirus Infection in Women with Kidney Transplant.
-
Incidence of De Novo Donor-Specific Antibodies Following Kidney Transplantation.
-
Incidence of Acute Rejection and Donor Specific Antibodies in Low-Immunological Risk Patients Treated by Tacrolimus and Mycophenolic Acid with or without Induction Therapy.
-
Incidence of Cytomegalovirus Infection Among Liver Transplant Recipients Maintained on a Cyclosporine vs. Tacrolimus-Based Immunosuppression Regimen.
-
Incidence of Donor-Specific Anti-HLA Antibodies in Non-HLA Sensitized Patients Given Tacrolimus Once or Twice Daily During the First Two Years Post-Transplantation.
-
Incidence of Fungal and Viral Infections Following Rituximab Use in Kidney Transplant Recipients.
-
Incidence of Late-Onset Complications Related to Immunosuppressive Drugs Following Adult to Adult Living Donor Liver Transplantation, Especially Focusing on De Novo Malignancy.
-
Incidence, Recurrence and Long Term Survival Post Chemotherapy in Renal Transplant Recipients with Post Transplant Lymphoproliferative Disorder: Single Center Study.
-
Incidental Hepatocellular Carcinoma in Explanted Livers: An Assessment After LIRADS Introduction.
-
Increase in Post-Transplant Mortality Under KAS.
-
Increased Expression of Fibrillin-1 and Presence of Fibroblastic Reticular Cells in Treg-Rich Organized Lymphoid Structures (TOLS) of Accepted Kidney Allografts.
-
Increased Gene Expression of TGF-β in Peripheral Blood Mononuclear Cells from Renal Transplant Patients with Polyomavirus BK Viremi.
-
Increased Ischemic Inflammation Induces Recipient Endogenous Memory CD4 Cell-Graft Dendritic Cell Interactions to Provide Help for Activation of Endogenous Memory CD8 T Cells.
-
Increased Long-Term Mortality 20 years After Living Kidney Donation.
-
Increased Pro-Inflammatory and Decreased Interferon-Related Gene Expression in Older as Compared with Younger Kidney Transplant Recipients.
-
Increased T Cell Exhaustion in Dialysis Patients.
-
Increased Use of Donation After Cardiac Death Donors Increases Access to Transplantation without Adverse Effect on Outcomes.
-
Increasing Liver Transplant Waitlist Dropout for Hepatocellular Carcinoma with Widening Geographical Disparities: Implications for Organ Allocation.
-
Increasing Living Donation by Implementing the Kidney Coach Program.
-
Increasing Organ Supply in the US: A Systematic Review of Presumed Consent vs. Informed Consent (2006-2016).
-
Increasing the Kidney Donor Pool by Expanding Limits on Body Mass Index and Age: A Single-Center Evaluation of Safety for Donors and Recipients.
-
Induced Pluripotent Stem Cell (iPS) Derived Schwann Cells to Enhance Functional Recovery Following Nerve Injury and Limb Allotransplantation.
-
Induction Immunotherapy in ECD and DGF Kidneys: Does ECD Equal Diminishing Induction Returns?
-
Induction in the Elderly: A Comparison of Basiliximab versus Rabbit Anti-Thymocyte Globulin After Kidney Transplantation.
-
Induction of Delayed Renal Allograft Tolerance Using Only Clinically Available Reagents in Non-Human Primates.
-
Induction of Durable Mixed Hematopoietic Chimerism and Immune Tolerance in Non-Human Primates.
-
Induction of Mixed Chimerism to Prolong Liver Allograft Survival in Cynomolgus Monkeys.
-
Induction of Proliferative Responses in B Cell and Plasma Cell Populations Following Proteasome Inhibitor Desensitization Treatment in Rhesus Macacques and Humans.
-
Induction of Sensitization and Resistance to Transplant Tolerance by Allogeneic Pregnancy.
-
Induction of Tolerance to Renal Allografts in Non Human Primates by Concomitant Donor-Matched Vascularized Osteomyocutaneous Allotransplantation.
-
Induction Therapy in Low Risk Elderly Kidney Transplant Recipients: Donor Factors.
-
Induction Treatment with Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplant Recipients with Planned Early Steroid Withdrawal.
-
Infections and Outcomes in Renal Transplantation Patients Using Alemtuzumab for Induction Immunosuppression: Preliminary Results.
-
Infectious Complications Following Hepatectomy for Pediatric Hepatoblastoma.
-
Inferior 10-Year Graft and Patient Survival After End-to-Side Reconstruction for Two Renal Arteries in Living Donor Renal Transplantation.
-
Inferior Graft and Patient Survival After Living Donor Renal Transplantation of Negatively Selected Right Kidneys.
-
Inflammasome, Unfolded Protein Response, and T Cell Immunity in DAIH.
-
Inflammation, Impaired Energy Metabolism and Synthetic Failure Characterize the Liver Transcriptome of End-Stage Idiopathic Pediatric Acute Liver Failure (PALF).
-
Inflammatory Conditions Dictate the Effect of MSC on B Cell Function.
-
Inflammatory Cytokines Are Associated with Angiotensin II Type 1 Receptor Antibodies and Vascular Inflammation in Pediatric Renal Transplantation.
-
Influence of an Enhanced Recovery Protocol in Laparoscopic Living Donor Nephrectomy.
-
Influence of Donor-Specific Antibodies on Renal Function in Kidney Transplant Recipients Following Early Switch from Calcineurin Inhibitor to Everolimus: Subanalysis from the ELEVATE Study.
-
Influence of Tacrolimus Metabolism Rate on Patients' Survival After Renal Transplantation.
-
Influenza Viral Dynamics in a Large Cohort of Transplant Patients with Natural Influenza Infection.
-
Infusion of Polyclonal Tregs Modulates Subclinical Kidney Transplant Inflammation: Final Report of TASK Pilot Trial.
-
Inhibition of Bruton Tyrosine Kinase Blocks Sensitization in Response to Allogeneic Skin Transplantation and Prolong Skin Graft Survival.
-
Inhibition of Heat Shock Protein 90 Suppresses the Expression of MHC Class I Molecules, but Not MHC Class II Molecules, on Endothelial Cells in Allografts.
-
Inhibition of Liver Natural Killer Cells Activation Through Co-Transplantation of Pre-Activated Mesenchymal Stem Cells Contributes to Improvement of Islet Graft Survival.
-
Inhibition of Memory T Cell Alloresponses by TIM-1+ B Cells.
-
Inhibition of Multiple Nodes in the PI3K/Akt/mTOR Pathway Synergistically Suppresses Epstein-Barr Virus B Cell Lymphomas.
-
Initial Experince with Total Pancreatectomy-Islet Auto-Transplantation (TP-IAT) for Chronic Pancreatitis at the University of Louisville.
-
iNKT Cell Activation Plus Veto Cell Transfer Yields Complete Chimerism in a Murine Sub-Lethal Bone Marrow Transplant Model.
-
Innate Lymphoid Cells Play a Critical Role in Regulating Allograft Homeostasis in Human Intestinal Transplantation.
-
Insulin Therapy in Pancreas Donors as a Predictor of Subsequent Transplant Outcome.
-
Integrated Magnetic-Electrochemical Exosome (iMEX) Technology to Detect Rejection in Kidney Transplant Recipients.
-
Integration of Kidney-Exchange, (Un)Specified Living Donor Transplantation, ABO Incompatible and Desensitisation Programs in a Computerized Allocation Program: A Simulation.
-
Integrative Analysis of ExomeSeq and Gene Expression Data for Identification of Novel Variants Associated with Antibody-Mediated Rejection in Kidney Transplant.
-
Intended and Unexpected Impact of the New Kidney Allocation System on a Large Volume Transplant Program.
-
Intensive Care Unit Enhanced Recovery Pathway for Liver Transplant Recipients: A Prospective, Observational Study.
-
Interruption of RAAS in Hypertensive Proteinuric Kidney Donors.
-
Intraabdominal Infections (IAI) and Bloodstream Infections in Small Intestinal and Multivisceral Transplants (IMVTX).
-
Intraomental Non-Purified Islet Transplantation Isolated from DCD Donor Pancreas.
-
Intraoperative Fluid Management During Pediatric Kidney Transplantation with Less Than 15kg Body Weight Using Transesophageal Echocardiaography as Hemodynamic Parameter.
-
Intravoxel Incoherent Motion MRI Is an Effective Way to Monitor Acute Allograft Rejection in Rat Models.
-
IP-10 Monoclonal Antibody Treatment Suppresses Inflammatory Components of IBMIR and Improves Pancreatic Islet Graft Function.
-
Is “Death with a Functioning Graft (DWF)” Really Death with Function? Data from the Long-Term Deterioration of Kidney Allograft Function (DeKAF) Study.
-
Is Deceased Donor Kidney Transplantation (DDTX) Justified in Patients with More Than 10 Years of Pre-TX Dialysis Exposure?
-
Is It Safe to Use Older Donor Liver Grafts for Older Recipients?
-
Is Lung Allocation Score Associated with Waitlist and Post-Transplant Survival?
-
Is Once-Daily Extended-Release Tacrolimus Better Than Twice-Daily Standard-Release Tacrolimus? A Meta-Analysis of Randomized Controlled Trials.
-
Is Peri-Transplant Plasmapheresis Effective in the Prevention of Recurrence of FSGS?
-
Is Reluctance to Accept Younger Kidney Donors Justified?
-
Is the Current Heart Allocation System Just and Fair for Blood Type O Recipients? – A Propensity-Matched Analysis of 34353 Patients in the UNOS Registry.
-
Is the Time of Appearance and Resolution of De Novo HLA-DP Donor Specific Antibodies Associated with Reduced Deleterious Effect on Lung Transplant Outcomes?
-
Is There a [bdquo]Weekend Effect“ in Kidney Transplantation? – A Single Center Study.
-
Is There a Role for Electronic Health Service in of Therapeutic Drug Monitoring of Immunosuppression?
-
Is There an Association Between Number of Outpatient Primary Care Visits (OPV) and Outcomes in Kidney Transplantation (KTP)?
-
Is There Any Difference Between ABO-Incompatible and ABO-Compatible Liver Transplantation? Oncologic Aspect.
-
Is Thymic Function Determining Rejection Onset in Heart Transplantation?
-
Ischemia Reperfusion Injury (IRI) Causes Local Release of Free Heme Which Aggravates Inflammation and Contributes to Delayed Graft Function.
-
Ischemia-Reperfusion Injury-Induced Innate Immune Signaling in Human Orthotopic Liver Transplantation.
-
Islet Rejection in Autoimmune NOD Mouse Recipients: Implications for Stem Cell Therapies.
-
Isoflurane Precondition Alleviated Murine Liver Ischemia and Reperfusion Injury by Restoring AMPK/mTOR-Mediated Autophagy.
-
Isolated Angiotensin II Receptor Type I Antibodies (AT1R) Are Not Associated with Active Antibody Mediated Rejection (ABMR) in Pediatric Renal Transplant Recipients.
-
It's Never too Early to Test: Frequent Anti-A2 Titer Monitoring in Blood Group B Patients is Necessary.
-
IVIG + Rituximab as Desensitization Agents to Reduce Donor Specific Antibodies and Improve Transplant Rates in Highly Hla Sensitized (HS) Awaiting Deceased Donor Kidney Transplantation.
-
IVIg+Rituximab Desensitization (DES) Combined with Alemtuzumab (ATZ) Induction Does Not Increase Risk for Viral Infections (VIs) and Associated Complications in HLA-Sensitized (HS) Kidney Transplant Patients (KTx Pts).
2017 American Transplant Congress
April 29-May 3, 2017 in Chicago, IL